Are Angiotensin II Receptor Blockers for Hypertension a Gleam of Hope or not Against COVID-19 Infection?

Numbers of infected people and deaths by COVID-19 are increasing every day worldwide and life has stopped to fight against this virus. There is an urgent need of a treatment against this pandemic. People having hypertension, cardiovascular diseases and diabetes conditions were reported as more vulnerable against COVID-19 infection. ACE2 is the entry receptor for COVID-19 virus and ACE2 blockers are widely used against abovementioned chronic diseases. ACE2 inhibitors can reduce oxidative stress levels in the tissues, when viral infections imbalance redox balance of the organs by elevating oxidative stress levels. Therefore, using ACE2 blockers may help to treat infected patients showing severe symptoms, especially the ones having diabetes, hypertension or cardiovascular diseases. However clinical trials are needed to understand whether this theory are correct or not.

PDF

___

1. Aydemir D, Ulusu NN. Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths? Pathog Glob Health 2020;114:109–110. [CrossRef]
2. Aydemir D, Ulusu NN. Correspondence: Angiotensin-converting enzyme 2 coated nanoparticles containing respiratory masks, chewing gums and nasal filters may be used for protection against COVID-19 infection. Travel Med Infect Dis 2020;101697. [CrossRef]
3. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr 2020;87:281–286. [CrossRef]
4. Arendse LB, Danser AHJ, Poglitsch M, et al. Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure. Pharmacol Rev 2019;71:539–570. [CrossRef]
5. Riordan JF. Angiotensin-I-converting enzyme and its relatives. Genome Biol 2003;4:225. https://genomebiology.biomedcentral.com/articles/10.1186/gb-2003-4-8-225
6. Guo J, Huang Z, Lin L, Lv J. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Am Heart Assoc 2020;7;9:e016219. [CrossRef]
7. Ozdemir S, Tandogan B, Ulusu NN, Turan B. Angiotensin II receptor blockage prevents diabetes-induced oxidative damage in rat heart. Folia Biol (Praha) 2009;55:11–16. https://fb.cuni.cz/Data/files/folia_biologica/volume_55_2009_1/fb2009A0003.pdf
8. Halter JB, Musi N, Horne MF, et al. High KP13 Diabetes and cardiovascular disease in older adults: current status and future directions. Diabetes 2014;63:2578–2589. [CrossRef]
9. Rehman ZU, Meng C, Sun Y, et al. Oxidative Stress in Poultry: Lessons from the Viral Infections. Oxid Med Cell Longev 2018;2018:5123147. [CrossRef]
10. Piri A, Kim HR, Hwang J. Prevention of damage caused by corona discharge-generated reactive oxygen species under electrostatic aerosol-to-hydrosol sampling. J Hazard Mater 2020;384:121477. [CrossRef]
11. Aydemir, D. and Ulusu, N.N. Correspondence: Importance of the validated serum biochemistry and hemogram parameters for rapid diagnosis and to prevent false negative results during COVID‐19 pandemic. Biotechnol Appl Biochem. 2020 May 3;10.1002/bab.1936. Online ahead of print. [CrossRef]